Methacycline

Methacycline

SCHEMBL127703

C=C1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@H]3[C@@H](O)[C@H]12.Cl

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Methacycline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 11/20 0.70
KDM4E B2RXH2 9/20 0.70
RECQL P46063 7/20 0.70
HPGD P15428 7/20 0.70
L3MBTL1 Q9Y468 7/20 0.70
MEN1 O00255 6/20 0.70
KMT2A Q03164 6/20 0.70
HSD17B10 Q99714 6/20 0.70
THRB P10828 5/20 0.70
MAPT P10636 5/20 0.70
POLB P06746 3/20 0.70
NR1I2 O75469 2/20 0.70
RAD52 P43351 1/20 0.70
USP2 O75604 7/20 0.69
SIRT5 Q9NXA8 2/20 0.69
LMNA P02545 2/20 0.69
MC4R P32245 1/20 0.69
ALDH1A1 P00352 4/20 0.50
ALOX15 P16050 2/20 0.50
HIF1A Q16665 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methacycline SCHEMBL5445227 1.00 TDP1 (0.70) TDP1KDM4ERECQLHPGDL3MBTL1
Methacycline SCHEMBL127702 1.00 TDP1 (0.70) TDP1KDM4ERECQLHPGDL3MBTL1
Methacycline SCHEMBL30582540 1.00 TDP1 (0.70) TDP1KDM4ERECQLHPGDL3MBTL1
Methacycline SCHEMBL2614978 0.99 TDP1 (0.70) TDP1KDM4ERECQLHPGDL3MBTL1
Methacycline SCHEMBL29376851 0.99 TDP1 (0.70) TDP1KDM4ERECQLHPGDL3MBTL1
Methacycline SCHEMBL17430778 0.99 TDP1 (0.70) TDP1KDM4ERECQLHPGDL3MBTL1
Methacycline SCHEMBL5523818 0.99 TDP1 (0.70) TDP1KDM4ERECQLHPGDL3MBTL1
Methacycline SCHEMBL19771282 0.99 TDP1 (0.70) TDP1KDM4ERECQLHPGDL3MBTL1
Methacycline SCHEMBL21133469 0.99 TDP1 (0.70) TDP1KDM4ERECQLHPGDL3MBTL1
Methacycline SCHEMBL13328119 0.99 TDP1 (0.70) TDP1KDM4ERECQLHPGDL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2593 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-220950188-U Airflow conveyer for methacycline hydrochloride 镇江高海生物药业有限公司 2024-05-14 CN claimed
CN-220750646-U Methylene terramycin hydrochloride stoving vacuum drier 镇江高海生物药业有限公司 2024-04-09 CN claimed
CN-220573393-U Swing type granulator for producing methacycline hydrochloride 镇江高海生物药业有限公司 2024-03-12 CN claimed
CN-220573430-U Methyleneoxytetracycline hydrochloride production mother liquor neutralization tank 镇江高海生物药业有限公司 2024-03-12 CN claimed
CN-117023746-A Treatment system for waste liquid generated in production of methacycline hydrochloride and application method of treatment system 镇江高海生物药业有限公司 2023-11-10 CN claimed
CN-110975881-B Dechlorination catalyst for synthesizing metacycline hydrochloride and preparation method and application thereof 扬州联博药业有限公司 2023-03-10 CN claimed
CN-114713193-A Nitrogen-doped magnetic porous carbon composite material and preparation method and application thereof 华南师范大学 2022-07-08 CN claimed
US-20220169680-A1 CELL-PENETRATING PEPTIDE BASED ON INFLUENZA VIRUS M2 PROTEIN INSTITUTE OF BASIC MEDICAL SCIENCES CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2022-06-02 US claimed
EP-3912989-A1 CELL-PENETRATING PEPTIDE BASED ON INFLUENZA VIRUS M2 PROTEIN Institute of Basic Medical Sciences Chinese Academy of Medical Sciences (CN) 2021-11-24 EP claimed
CN-112912386-A Cell penetrating peptide based on influenza virus M2 protein 中国医学科学院基础医学研究所 2021-06-04 CN claimed
US-20020044968-A1 High amount of plasticizer to facilitate plasticization of the matrix material at low shear and then reduced prior to adding the encapsulant to reduce post extrusion GENERAL MILLS, INC. 2002-04-18 US claimed
JP-2002511777-A 2002-04-16 JP claimed
EP-1119345-A1 ENCAPSULATION OF SENSITIVE LIQUID COMPONENTS INTO A MATRIX TO OBTAIN DISCRETE SHELF-STABLE PARTICLES GENERAL MILLS, INC. (US) 2001-08-01 EP claimed
WO-2000021504-A1 ENCAPSULATION OF SENSITIVE LIQUID COMPONENTS INTO A MATRIX TO OBTAIN DISCRETE SHELF-STABLE PARTICLES GENERAL MILLS, INC. (US) 2000-04-20 WO claimed
EP-0935523-A4 EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES GEN MILLS INC (US) 1999-12-29 EP claimed
US-5948416-A LEAVE ON SKIN CARE COMPOSITION; HYDROPHOBIC STRUCTURING AGENT; HYDROPHILIC CATIONIC SURFACTANT; ACTIVE COMPOUND THE PROCTER & GAMBLE COMPANY (US) 1999-09-07 US claimed
EP-0935523-A1 EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES GENERAL MILLS, INC. (US) 1999-08-18 EP claimed
US-5780049-A Enhanced skin penetration system for improved topical delivery of drugs RICHARDSON-VICKS INC. (US) 1998-07-14 US claimed
WO-1998018610-A1 EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES LENGERICH BERNHARD H VAN (US) 1998-05-07 WO claimed
US-3966808-A HALOGENATION, DEHYDRATION, METHACYCLINE HYDROCHLORIDE RACHELLE LABORATORIES ITALIA, S.P.A. (IT) 1976-06-29 US claimed